ATI Pharmacology CMS Questions and Answers 2025/2026 -
Verified & Correct with Rationales - 206 Questions and Answers
Already Graded A+ Premium Exam Tested And Verified
Subject Area Pharmacology
Description This advanced pharmacology examination assesses deep conceptual
understanding of drug mechanisms, clinical application, pharmacokinetics, and
pharmacodynamics. Questions integrate recent guidelines and evidence-based
practices, requiring synthesis across therapeutic classes and patient-specific
variables.
Expected Grade A+
Total Questions 206
Duration 3 hours
Learning Outcomes 1. Critically evaluate pharmacokinetic and pharmacodynamic principles in drug
therapy.
2. Integrate autonomic and cardiovascular pharmacology for complex clinical
scenarios.
3. Analyze antimicrobial and chemotherapeutic strategies based on resistance
patterns and molecular targets.
4. Apply endocrine, pain, and anticoagulation management principles with
contemporary guidelines.
Accreditation ACPE accredited / US university standards for pharmacology assessment
Page 1
,Question 1 of 206
A drug is highly bound to plasma albumin (99% bound) and has a low volume of distribution (4 L).
If a second drug that also binds to albumin with higher affinity is co-administered, which of the
following is most likely to occur?
A. Decreased free fraction of the first drug, leading to reduced efficacy
B. Increased free fraction of the first drug, potentially causing toxicity
C. No change in free fraction because binding sites are saturated
D. Increased volume of distribution of the first drug due to displacement
The correct answer is:
Correct Action: Increased free fraction of the first drug, potentially causing toxicity
Rationales
• Increased free fraction of the first drug, potentially causing toxicity (Correct):
This is the correct action. Displacement from albumin binding sites increases the free (unbound) concentration of the first
drug. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free concentration and potential
toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect because displacement occurs
• Decreased free fraction of the first drug, leading to reduced efficacy (Incorrect):
This option is not appropriate. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free
concentration and potential toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect
because displacement occurs despite saturation; option D is not typical-Vd may change slightly but not primarily due to
• No change in free fraction because binding sites are saturated (Incorrect):
This option is not appropriate. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free
concentration and potential toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect
because displacement occurs despite saturation; option D is not typical-Vd may change slightly but not primarily due to
• Increased volume of distribution of the first drug due to displacement (Incorrect):
This option is not appropriate. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free
concentration and potential toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect
because displacement occurs despite saturation; option D is not typical-Vd may change slightly but not primarily due to
Page 2
,Question 2 of 206
A novel drug acts as a partial agonist at 1-adrenoceptors and a weak antagonist at 1-adrenoceptors.
Which of the following best describes its net cardiovascular effect?
A. Decreased heart rate and decreased peripheral resistance
B. Increased contractility and increased peripheral resistance
C. Decreased heart rate and increased peripheral resistance
D. No change in heart rate or blood pressure due to opposing actions
The correct answer is:
Correct Action: Decreased heart rate and decreased peripheral resistance
Rationales
• Decreased heart rate and decreased peripheral resistance (Correct):
This is the correct action. Partial agonism at 1-receptors produces a submaximal increase in heart rate and contractility, but
the net effect is a slight decrease in heart rate due to intrinsic sympathomimetic activity (ISA) in low sympathetic tone?
Actually, a partial agonist can act as an antagonist when endogenous catecholamines are high, but typically chronic use
• Increased contractility and increased peripheral resistance (Incorrect):
This option is not appropriate. However, 1 antagonism dilates arterioles, decreasing peripheral resistance. Combining
bradycardia and vasodilation lowers blood pressure
• Decreased heart rate and increased peripheral resistance (Incorrect):
This option is not appropriate. However, 1 antagonism dilates arterioles, decreasing peripheral resistance. Combining
bradycardia and vasodilation lowers blood pressure
• No change in heart rate or blood pressure due to opposing actions (Incorrect):
This option is not appropriate. However, 1 antagonism dilates arterioles, decreasing peripheral resistance. Combining
bradycardia and vasodilation lowers blood pressure
Page 3
, Question 3 of 206
A patient with schizophrenia is stabilized on clozapine but develops severe constipation and weight
gain. The prescriber considers switching to another second-generation antipsychotic. Which of the
following has the most favorable metabolic profile and lowest risk of constipation?
A. Risperidone
B. Olanzapine
C. Ziprasidone
D. Paliperidone
The correct answer is:
Correct Action: Ziprasidone
Rationales
• Ziprasidone (Correct):
This is the correct action. Ziprasidone has a neutral effect on weight and minimal anticholinergic effects (thus low
constipation risk). Risperidone and paliperidone cause moderate weight gain and some constipation. Olanzapine is
associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing to
• Risperidone (Incorrect):
This option is not appropriate. Risperidone and paliperidone cause moderate weight gain and some constipation.
Olanzapine is associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing
to constipation
• Olanzapine (Incorrect):
This option is not appropriate. Risperidone and paliperidone cause moderate weight gain and some constipation.
Olanzapine is associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing
to constipation
• Paliperidone (Incorrect):
This option is not appropriate. Risperidone and paliperidone cause moderate weight gain and some constipation.
Olanzapine is associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing
to constipation
Page 4
Verified & Correct with Rationales - 206 Questions and Answers
Already Graded A+ Premium Exam Tested And Verified
Subject Area Pharmacology
Description This advanced pharmacology examination assesses deep conceptual
understanding of drug mechanisms, clinical application, pharmacokinetics, and
pharmacodynamics. Questions integrate recent guidelines and evidence-based
practices, requiring synthesis across therapeutic classes and patient-specific
variables.
Expected Grade A+
Total Questions 206
Duration 3 hours
Learning Outcomes 1. Critically evaluate pharmacokinetic and pharmacodynamic principles in drug
therapy.
2. Integrate autonomic and cardiovascular pharmacology for complex clinical
scenarios.
3. Analyze antimicrobial and chemotherapeutic strategies based on resistance
patterns and molecular targets.
4. Apply endocrine, pain, and anticoagulation management principles with
contemporary guidelines.
Accreditation ACPE accredited / US university standards for pharmacology assessment
Page 1
,Question 1 of 206
A drug is highly bound to plasma albumin (99% bound) and has a low volume of distribution (4 L).
If a second drug that also binds to albumin with higher affinity is co-administered, which of the
following is most likely to occur?
A. Decreased free fraction of the first drug, leading to reduced efficacy
B. Increased free fraction of the first drug, potentially causing toxicity
C. No change in free fraction because binding sites are saturated
D. Increased volume of distribution of the first drug due to displacement
The correct answer is:
Correct Action: Increased free fraction of the first drug, potentially causing toxicity
Rationales
• Increased free fraction of the first drug, potentially causing toxicity (Correct):
This is the correct action. Displacement from albumin binding sites increases the free (unbound) concentration of the first
drug. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free concentration and potential
toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect because displacement occurs
• Decreased free fraction of the first drug, leading to reduced efficacy (Incorrect):
This option is not appropriate. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free
concentration and potential toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect
because displacement occurs despite saturation; option D is not typical-Vd may change slightly but not primarily due to
• No change in free fraction because binding sites are saturated (Incorrect):
This option is not appropriate. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free
concentration and potential toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect
because displacement occurs despite saturation; option D is not typical-Vd may change slightly but not primarily due to
• Increased volume of distribution of the first drug due to displacement (Incorrect):
This option is not appropriate. With a low Vd, the free drug is largely confined to plasma, leading to a higher peak free
concentration and potential toxicity until redistribution and elimination occur. Option A is opposite; option C is incorrect
because displacement occurs despite saturation; option D is not typical-Vd may change slightly but not primarily due to
Page 2
,Question 2 of 206
A novel drug acts as a partial agonist at 1-adrenoceptors and a weak antagonist at 1-adrenoceptors.
Which of the following best describes its net cardiovascular effect?
A. Decreased heart rate and decreased peripheral resistance
B. Increased contractility and increased peripheral resistance
C. Decreased heart rate and increased peripheral resistance
D. No change in heart rate or blood pressure due to opposing actions
The correct answer is:
Correct Action: Decreased heart rate and decreased peripheral resistance
Rationales
• Decreased heart rate and decreased peripheral resistance (Correct):
This is the correct action. Partial agonism at 1-receptors produces a submaximal increase in heart rate and contractility, but
the net effect is a slight decrease in heart rate due to intrinsic sympathomimetic activity (ISA) in low sympathetic tone?
Actually, a partial agonist can act as an antagonist when endogenous catecholamines are high, but typically chronic use
• Increased contractility and increased peripheral resistance (Incorrect):
This option is not appropriate. However, 1 antagonism dilates arterioles, decreasing peripheral resistance. Combining
bradycardia and vasodilation lowers blood pressure
• Decreased heart rate and increased peripheral resistance (Incorrect):
This option is not appropriate. However, 1 antagonism dilates arterioles, decreasing peripheral resistance. Combining
bradycardia and vasodilation lowers blood pressure
• No change in heart rate or blood pressure due to opposing actions (Incorrect):
This option is not appropriate. However, 1 antagonism dilates arterioles, decreasing peripheral resistance. Combining
bradycardia and vasodilation lowers blood pressure
Page 3
, Question 3 of 206
A patient with schizophrenia is stabilized on clozapine but develops severe constipation and weight
gain. The prescriber considers switching to another second-generation antipsychotic. Which of the
following has the most favorable metabolic profile and lowest risk of constipation?
A. Risperidone
B. Olanzapine
C. Ziprasidone
D. Paliperidone
The correct answer is:
Correct Action: Ziprasidone
Rationales
• Ziprasidone (Correct):
This is the correct action. Ziprasidone has a neutral effect on weight and minimal anticholinergic effects (thus low
constipation risk). Risperidone and paliperidone cause moderate weight gain and some constipation. Olanzapine is
associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing to
• Risperidone (Incorrect):
This option is not appropriate. Risperidone and paliperidone cause moderate weight gain and some constipation.
Olanzapine is associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing
to constipation
• Olanzapine (Incorrect):
This option is not appropriate. Risperidone and paliperidone cause moderate weight gain and some constipation.
Olanzapine is associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing
to constipation
• Paliperidone (Incorrect):
This option is not appropriate. Risperidone and paliperidone cause moderate weight gain and some constipation.
Olanzapine is associated with significant weight gain and metabolic syndrome, and has anticholinergic effects contributing
to constipation
Page 4
